Lesson plan
ADB-BINACA
ADB-BINACA (also known as ADMB-BZINACA using EMCDDA naming standards ) is a cannabinoid designer drug that has been found as an ingredient in some synthetic cannabis products. It was originally developed by Pfizer as a potential analgesic, and is a potent agonist of the CB 1 receptor with a binding affinity (K i ) of 0.33 nM and an EC 50 of 14.7 nM.
Article summary
ADB-BINACA (also known as ADMB-BZINACA using EMCDDA naming standards ) is a cannabinoid designer drug that has been found as an ingredient in some synthetic cannabis products. It was originally developed by Pfizer as a potential analgesic, and is a potent agonist of the CB 1 receptor with a binding affinity (K i ) of 0.33 nM and an EC 50 of 14.7 nM.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.